Advertisement

Topics

Evaluate: Japanese Pharmaceutical Market Set to Grow 3.3% (CAGR) Between 2017 and 2022, Significantly Lower than the Worldwide Outlook (6.5% CAGR)

09:00 EDT 1 Aug 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Latest growth forecasts show optimism surrounding new therapies coming to market counterbalanced by more stringent pricing policy enforcement According to life science commercial intelligence firm, Evaluate, the enfor...

Other Sources for this Article

Evaluate and EP Vantage (for general questions)
Christine Lindgren
+1 617-866-3906
christine.lindgren@evaluategroup.com
or
Instinctif Partners (for non-U.S. media)
Gemma Harris/Melanie Toyne Sewell
+44 (0) 20 7457 2020
evaluate@instinctif.com
or
Jani Communications (for U.S. media)
Janice Foley
+1-617-823-5555
janifoley@verizon.net
or
Edelman Japan KK (For Japanese media)
Yamada/Masaki
TEL: +81(3)-4360-9000
evaluatejapanpr@edelman.com

NEXT ARTICLE

More From BioPortfolio on "Evaluate: Japanese Pharmaceutical Market Set to Grow 3.3% (CAGR) Between 2017 and 2022, Significantly Lower than the Worldwide Outlook (6.5% CAGR)"

Quick Search
Advertisement
 

Relevant Topic

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...